Overview

Lopinavir Capsules to Kaletra or Invirase Tablets

Status:
Completed

Trial end date:
2009-02-01

Target enrollment:

Participant gender:

Summary

This study will compare the benefit for patients switching from Kaletra® to Invirase® tablets over remaining on Kaletra® (based on randomization), to elicit the lipid benefits inferred in previous studies

Phase:

Phase 4

Details

Lead Sponsor:

Royal Free Hampstead NHS Trust

Collaborator:

Roche Pharma AG

Treatments:

Lopinavir
Ritonavir
Saquinavir